1. Home
  2. TGTX vs FSS Comparison

TGTX vs FSS Comparison

Compare TGTX & FSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$38.65

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Federal Signal Corporation

FSS

Federal Signal Corporation

HOLD

Current Price

$112.12

Market Cap

6.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGTX
FSS
Founded
1993
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.6B
IPO Year
2008
1994

Fundamental Metrics

Financial Performance
Metric
TGTX
FSS
Price
$38.65
$112.12
Analyst Decision
Strong Buy
Buy
Analyst Count
5
4
Target Price
$49.80
$131.75
AVG Volume (30 Days)
2.1M
375.8K
Earning Date
05-04-2026
04-29-2026
Dividend Yield
N/A
0.46%
EPS Growth
1746.67
14.57
EPS
0.12
1.14
Revenue
$2,785,000.00
$2,180,500,000.00
Revenue This Year
$49.08
$20.94
Revenue Next Year
$26.69
$6.79
P/E Ratio
$326.42
$97.54
Revenue Growth
N/A
17.14
52 Week Low
$25.37
$92.48
52 Week High
$44.65
$132.89

Technical Indicators

Market Signals
Indicator
TGTX
FSS
Relative Strength Index (RSI) 52.03 46.24
Support Level $33.05 $106.30
Resistance Level $44.65 $114.41
Average True Range (ATR) 1.90 3.23
MACD -0.42 -0.90
Stochastic Oscillator 38.19 20.80

Price Performance

Historical Comparison
TGTX
FSS

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, it has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. Its pipeline includes UBLITUXIMAB, SUB-Q UBLITUXIMAB, and AZER-CEL. Geographically, it generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from the international market.

About FSS Federal Signal Corporation

Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates through two segments. The Environmental Solutions Group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group manufactures and supplies comprehensive systems and products used by law enforcement, fire rescue, and industrial sites to protect people and property. Its offerings include systems for community alerting and industrial communications. The company generates the majority of its revenue from the Environmental Solutions Group segment.

Share on Social Networks: